ACF Investors’ Delta Fund led the round with participation from Mercia’s EIS fund. Simon Cartmell also led a solo investment.
Axis Spine Technologies will use the funds to launch devices in the U.S. and further develop its Oblique and Lateral cage implant systems.
The Axis-ALIF received FDA-clearance in May 2020, and the first surgery was completed with the devices in Atlanta in November 2020.
Note: Conversion from pound to USD was current as of Feb. 24.
More articles on surgery centers:
Amazon’s healthcare moves: 7 notes for ASCs and physicians
What ASC management company had the best 2020? & more — 9 ASC industry notes
3 joint-venture ASCs opened or announced in January
